We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNB:NYSEF.N.B. Corporation Analysis

Data as of 2026-06-14 - not real-time

$18.64

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

F.N.B. Corp. is trading at $18.64, just below the calculated resistance of $18.68 and comfortably above the support level of $16.99, indicating a tight near‑term range. The 14‑day RSI of 68 signals the stock is approaching overbought territory, while a bullish MACD histogram (+0.12) suggests lingering upward momentum. Volume is on an increasing trend, supporting the recent price gains. At a trailing P/E of 11.5, the stock is priced well below the industry average P/E of 16.8, hinting at a value edge, yet the DCF‑derived fair value of $16.96 is beneath the current price, tempering the upside narrative. Revenue growth of 9.6% and an operating margin of 42% underscore solid earnings power, complemented by a 2.79% dividend yield and a modest 29.6% payout ratio, which together point to dividend sustainability. The upside/downside estimate of roughly 10% aligns with the modest upside potential above the resistance level. Volatility over the past 30 days is elevated at 22%, and the beta around 1.0 reflects market‑line sensitivity, adding a moderate risk dimension. Overall, the stock offers a blend of modest growth, attractive valuation relative to peers, and a reliable dividend, but short‑term price pressure near resistance and overbought signals warrant a cautious stance.
Investors looking for a balanced exposure may consider a medium‑term buy, leveraging the undervalued valuation metrics and stable cash flow, while maintaining vigilance on technical overbought cues. For the long haul, the consistent dividend and steady profitability support a hold‑to‑buy recommendation, whereas the immediate term may be best approached with a hold or light trimming until a clearer breakout or pull‑back clarifies direction.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering at resistance with limited upside
  • RSI near overbought levels
  • Increasing volume but bullish MACD may be fading

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation below industry P/E and P/B benchmarks
  • Revenue growth of ~9% and strong operating margins
  • Sustainable dividend yield and low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable dividend and solid cash flow generation
  • Consistent profitability with ROE near 9%
  • Balanced risk profile with low geographic and currency exposure

Key Metrics & Analysis

Financial Health

Revenue Growth9.60%
Profit Margin34.08%
P/E Ratio11.5
ROE8.85%
ROA1.17%
P/B Ratio1.0
Op. Cash Flow$569.0M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI67.9
Support$16.99
Resistance$18.68
MA 20$17.59
MA 50$17.62
MA 200$16.95
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$16.96
Target Price$20.63
Upside/Downside10.65%
GradeFair
TypeBlend
Dividend Yield2.79%

Risk Assessment

Beta1.06
Volatility22.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.